- Home
- VALN vs AMRK Comparison
VALN vs AMRK Comparison
Compare VALN & AMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- AMRK
- Stock Information
- Founded
- VALN 2012
- AMRK 1965
- Country
- VALN France
- AMRK United States
- Employees
- VALN N/A
- AMRK N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- AMRK Other Specialty Stores
- Sector
- VALN Health Care
- AMRK Industrials
- Exchange
- VALN Nasdaq
- AMRK Nasdaq
- Market Cap
- VALN 510.7M
- AMRK 576.5M
- IPO Year
- VALN 2021
- AMRK N/A
- Fundamental
- Price
- VALN $6.79
- AMRK $23.57
- Analyst Decision
- VALN Strong Buy
- AMRK Buy
- Analyst Count
- VALN 2
- AMRK 4
- Target Price
- VALN $16.00
- AMRK $41.75
- AVG Volume (30 Days)
- VALN 142.9K
- AMRK 339.1K
- Earning Date
- VALN 05-06-2025
- AMRK 05-06-2025
- Dividend Yield
- VALN N/A
- AMRK 3.38%
- EPS Growth
- VALN N/A
- AMRK N/A
- EPS
- VALN N/A
- AMRK 2.15
- Revenue
- VALN $175,564,758.00
- AMRK $10,593,047,000.00
- Revenue This Year
- VALN $19.17
- AMRK $14.42
- Revenue Next Year
- VALN $26.31
- AMRK $1.23
- P/E Ratio
- VALN N/A
- AMRK $10.96
- Revenue Growth
- VALN 10.32
- AMRK 5.93
- 52 Week Low
- VALN $3.62
- AMRK $20.60
- 52 Week High
- VALN $9.50
- AMRK $47.39
- Technical
- Relative Strength Index (RSI)
- VALN 50.63
- AMRK 43.92
- Support Level
- VALN $6.54
- AMRK $22.48
- Resistance Level
- VALN $7.30
- AMRK $24.13
- Average True Range (ATR)
- VALN 0.48
- AMRK 1.47
- MACD
- VALN 0.01
- AMRK 0.04
- Stochastic Oscillator
- VALN 56.79
- AMRK 53.13
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About AMRK A-Mark Precious Metals Inc.
A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.